These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 29112018)

  • 21. Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer.
    Ryan ÉJ; Creavin B; Khaw YL; Kelly ME; Mohan HM; Geraghty R; Ryan EJ; Kennelly R; Hanly A; Martin ST; Fennelly D; McDermott R; Gibbons D; O'Connell PR; Sheahan K; Winter DC
    BJS Open; 2018 Dec; 2(6):456-463. PubMed ID: 30511046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting.
    Betge J; Pollheimer MJ; Lindtner RA; Kornprat P; Schlemmer A; Rehak P; Vieth M; Hoefler G; Langner C
    Cancer; 2012 Feb; 118(3):628-38. PubMed ID: 21751188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer.
    Barresi V; Branca G; Ieni A; Reggiani Bonetti L; Baron L; Mondello S; Tuccari G
    Virchows Arch; 2014 Jun; 464(6):655-62. PubMed ID: 24771119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis.
    Gil-Raga M; Jantus-Lewintre E; Gallach S; Giner-Bosch V; Frangi-Caregnato A; Safont-Aguilera MJ; Garde-Noguera J; Zorraquino-Pina E; García-Martínez M; Camps-Herrero C
    Clin Transl Oncol; 2018 Nov; 20(11):1422-1429. PubMed ID: 29802524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.
    Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S
    In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study.
    Stoffel EM; Erichsen R; Frøslev T; Pedersen L; Vyberg M; Koeppe E; Crockett SD; Hamilton SR; Sørensen HT; Baron JA
    Gastroenterology; 2016 Nov; 151(5):870-878.e3. PubMed ID: 27443823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer.
    Neumann J; Heinemann V; Engel J; Kirchner T; Stintzing S
    Virchows Arch; 2018 Aug; 473(2):199-207. PubMed ID: 29675807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of hMLH1 or hMSH2 expression as a stage-dependent prognostic factor in sporadic colorectal cancers.
    Park JW; Chang HJ; Park S; Kim BC; Kim DY; Baek JY; Kim SY; Oh JH; Choi HS; Park SC; Jeong SY
    Ann Surg Oncol; 2010 Nov; 17(11):2839-46. PubMed ID: 20549564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
    Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
    Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
    Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
    Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair.
    Alex AK; Siqueira S; Coudry R; Santos J; Alves M; Hoff PM; Riechelmann RP
    Clin Colorectal Cancer; 2017 Sep; 16(3):228-239. PubMed ID: 28063788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.
    Koelzer VH; Herrmann P; Zlobec I; Karamitopoulou E; Lugli A; Stein U
    BMC Cancer; 2015 Mar; 15():160. PubMed ID: 25884643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
    Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
    Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators.
    Yang M; Rehman AU; Zuo C; Sheehan CE; Lee EC; Lin J; Zhao Z; Choi E; Lee H
    Cancer Med; 2016 Jul; 5(7):1510-8. PubMed ID: 27165693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis.
    Haraldsdottir S; Roth R; Pearlman R; Hampel H; Arnold CA; Frankel WL
    Fam Cancer; 2016 Apr; 15(2):253-60. PubMed ID: 26666765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and predictive role of DNA mismatch repair status in stage II-III colorectal cancer: A systematic review and meta-analysis.
    Deng Z; Qin Y; Wang J; Wang G; Lang X; Jiang J; Xie K; Zhang W; Xu H; Shu Y; Zhang Y
    Clin Genet; 2020 Jan; 97(1):25-38. PubMed ID: 31432497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.
    Ueno H; Hase K; Hashiguchi Y; Shimazaki H; Yoshii S; Kudo SE; Tanaka M; Akagi Y; Suto T; Nagata S; Matsuda K; Komori K; Yoshimatsu K; Tomita Y; Yokoyama S; Shinto E; Nakamura T; Sugihara K
    J Gastroenterol; 2014 Sep; 49(9):1314-23. PubMed ID: 24065123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters.
    Ueno H; Hase K; Hashiguchi Y; Shimazaki H; Tanaka M; Miyake O; Masaki T; Shimada Y; Kinugasa Y; Mori Y; Kishimoto M; Kameoka S; Sato Y; Matsuda K; Nakadoi K; Shinto E; Nakamura T; Sugihara K
    Am J Surg Pathol; 2014 Feb; 38(2):197-204. PubMed ID: 24418853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.